| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | MIRATI THERAPEUTICS INC COM | 2,023,232 | 63,934,000 | 55.20% | ||
| 2 | Aquinox Pharmaceuticals Inc | 809,415 | 10,101,000 | 8.72% | ||
| 3 | BLUEPRINT MEDICINES CORP COM | 313,626 | 8,261,000 | 7.13% | ||
| 4 | SEATTLE GENETICS INC | 160,000 | 7,181,000 | 6.20% | ||
| 5 | KURA ONCOLOGY INC | 654,595 | 5,499,000 | 4.75% | ||
| 6 | VITAE PHARMACEUTICALS INC | 250,270 | 4,530,000 | 3.91% | ||
| 7 | ARADIGM CORP COM | 1,101,513 | 4,373,000 | 3.78% | ||
| 8 | ZOGENIX INC | 225,000 | 3,317,000 | 2.86% | ||
| 9 | CELLADON CORP | 1,399,991 | 2,058,000 | 1.78% | ||
| 10 | AKARI THERAPEUTICS PLC | 139,899 | 2,029,000 | 1.75% | ||
| 11 | SOPHIRIS BIO INC | 1,000,000 | 1,780,000 | 1.54% | ||
| 12 | Nabriva Therapeutics AG | 176,710 | 1,688,000 | 1.46% | ||
| 13 | NEXVET BIOPHARMA PUB LTD CO | 154,840 | 528,000 | 0.46% | ||
| 14 | ALDEYRA THERAPEUTICS INC | 63,146 | 428,000 | 0.37% | ||
| 15 | ESSA Pharma | 28,100 | 119,000 | 0.10% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950123-16-015087, filed 2016.02.16).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
